NAVIDEA BIOPHARMACEUTICALS, INC. Quarterly Operating Lease, Payments in USD from Q1 2019 to Q1 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Navidea Biopharmaceuticals, Inc. quarterly/annual Operating Lease, Payments history and growth rate from Q1 2019 to Q1 2023.
  • Navidea Biopharmaceuticals, Inc. Operating Lease, Payments for the quarter ending March 31, 2023 was $9.44K, a 89.9% decline year-over-year.
  • Navidea Biopharmaceuticals, Inc. annual Operating Lease, Payments for 2022 was $291K, a 15.4% decline from 2021.
  • Navidea Biopharmaceuticals, Inc. annual Operating Lease, Payments for 2021 was $344K, a 1.55% increase from 2020.
  • Navidea Biopharmaceuticals, Inc. annual Operating Lease, Payments for 2020 was $339K, a 2.73% increase from 2019.
Operating Lease, Payments, Quarterly (USD)
Operating Lease, Payments, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2023 $9.44K -$84.4K -89.9% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-11
Q1 2022 $93.9K +$1.18K +1.27% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q1 2021 $92.7K +$1.71K +1.88% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q1 2020 $91K -$6K -6.19% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-13
Q1 2019 $97K Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.